Cargando…

What Is Stopping the Use of Genetically Modified Insects for Disease Control?

Detalles Bibliográficos
Autores principales:	Panjwani, Anusha, Wilson, Anthony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053591/ https://www.ncbi.nlm.nih.gov/pubmed/27711161 http://dx.doi.org/10.1371/journal.ppat.1005830

Ejemplares similares

When it comes to stopping tuberculosis, what is actually “missing”?
por: Fatah, Farahdiba Zalika, et al.
Publicado: (2022)

Opinion: To assess marine cloud brightening's technical feasibility, we need to know what to study—and when to stop
por: Diamond, Michael S., et al.
Publicado: (2022)

Stop Discussing New Medical Specialty Boards
por: Choung, Ji Tae
Publicado: (2018)

Insects and Public Health: An Overview
por: Belluco, Simone, et al.
Publicado: (2023)

The challenge of clinical adoption—the insurmountable obstacle that will stop machine learning?
por: Taylor, Jonathan, et al.
Publicado: (2018)

The Probing Behavior Component of Disease Transmission in Insect-Transmitted Bacterial Plant Pathogens
por: Ebert, Timothy A.
Publicado: (2019)

Does reduced smoking if you can’t stop make any difference?
por: Begh, Rachna, et al.
Publicado: (2015)

Extensive Partnership, Collaboration, and Teamwork is Required to Stop the COVID-19 Outbreak
por: Chakraborty, Chiranjib, et al.
Publicado: (2020)

A 43-year-old patient presenting with marked eosinophilia and multisystem disease
por: Panjwani, Amit, et al.
Publicado: (2016)

Can live-attenuated SARS-CoV-2 vaccine contribute to stopping the pandemic?
por: Tang, Patrick Chun Hean, et al.
Publicado: (2022)

New Prospects for Research on Manipulation of Insect Vectors by Pathogens
por: Lefèvre, Thierry, et al.
Publicado: (2006)

Beenomes to Bombyx: future directions in applied insect genomics
por: Evans, Jay D, et al.
Publicado: (2003)

Adequacy and sufficiency evaluation of existing EFSA guidelines for the molecular characterisation, environmental risk assessment and post‐market environmental monitoring of genetically modified insects containing engineered gene drives
por: Naegeli, Hanspeter, et al.
Publicado: (2020)

Control Using Genetically Modified Insects Poses Problems for Regulators
por: Lehane, Michael J., et al.
Publicado: (2012)

What use is the human genome for understanding the mouse?
por: Denny, Paul, et al.
Publicado: (2001)

Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease in the Era of Disease-Modifying Treatments
por: Paraskevas, George P., et al.
Publicado: (2021)

Short structural variants as informative genetic markers for ALS disease risk and progression
por: Theunissen, Frances, et al.
Publicado: (2022)

An interesting case of undiagnosed pleural effusion
por: Panjwani, Amit, et al.
Publicado: (2017)

Insulin Withdrawal in Diabetic Kidney Disease: What Are We Waiting for?
por: Morillas, Carlos, et al.
Publicado: (2021)

DNA methylation studies using twins: what are they telling us?
por: Bell, Jordana T, et al.
Publicado: (2012)

An uncommon cause of pleural effusion
por: Panjwani, Amit, et al.
Publicado: (2019)

Guidance on allergenicity assessment of genetically modified plants
por: Naegeli, Hanspeter, et al.
Publicado: (2017)

Integrating vector control across diseases
por: Golding, Nick, et al.
Publicado: (2015)

Is the gut microbiome of insects a potential source to meet UN sustainable development goals to eliminate plastic pollution?
por: Siddiqui, Ruqaiyyah, et al.
Publicado: (2023)

Response to mass casualty events: from the battlefield to the Stop the Bleed campaign
por: Knudson, M Margaret, et al.
Publicado: (2016)

The Modified Vaccination Technique
por: Barabas, Arpad, et al.
Publicado: (2018)

What Do We Really Know about How CD4 T Cells Control Mycobacterium tuberculosis?
por: Torrado, Egidio, et al.
Publicado: (2011)

Genomics: what is realistically achievable?
por: Overbeek, Ross
Publicado: (2000)

Overcoming Technical and Market Barriers to Enable Sustainable Large-Scale Production and Consumption of Insect Proteins in Europe: A SUSINCHAIN Perspective
por: Veldkamp, Teun, et al.
Publicado: (2022)

Use of Insect Promoters in Genetic Engineering to Control Mosquito-Borne Diseases
por: Bottino-Rojas, Vanessa, et al.
Publicado: (2022)

Towards the concept of disease-modifier in post-stroke or vascular cognitive impairment: a consensus report
por: Bordet, Régis, et al.
Publicado: (2017)

The intriguing phenomenon of cross-kingdom infections of plant and insect viruses to fungi: Can other animal viruses also cross-infect fungi?
por: Andika, Ida Bagus, et al.
Publicado: (2023)

What is complex about complex disorders?
por: Mitchell, Kevin J
Publicado: (2012)

Biodiversity Models: What If Unsaturation Is the Rule?
por: Mateo, Rubén G., et al.
Publicado: (2017)

Primary Vesicoureteral reflux and chronic kidney disease in pediatric population. What we have learnt?
por: Andrioli, Veridiana, et al.
Publicado: (2020)

Complex genetic diseases: controversy over the Croesus code
por: Wright, Alan F, et al.
Publicado: (2001)

Spectrum of MRI findings of foetal alcohol syndrome disorders—what we know and what we need to know!
por: Sharif, Saad, et al.
Publicado: (2023)

Scientific Opinion on application EFSA‐GMO‐NL‐2016‐132 for authorisation of genetically modified of insect‐resistant and herbicide‐tolerant soybean DAS–81419–2 × DAS–44406–6 for food and feed uses, import and processing submitted in accordance with Regulation (EC) No 1829/2003 by Dow Agrosciences LCC
por: Naegeli, Hanspeter, et al.
Publicado: (2020)

Certifying achievement in the control of Chagas disease native vectors: what is a viable scenario?
por: Hashimoto, Ken, et al.
Publicado: (2014)

Killing a Killer: What Next for Smallpox?
por: McFadden, Grant
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_lo123uv9k6uouea1n7f9nlsaf4